310 related articles for article (PubMed ID: 25678582)
21. Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells.
Deauvieau F; Ollion V; Doffin AC; Achard C; Fonteneau JF; Verronese E; Durand I; Ghittoni R; Marvel J; Dezutter-Dambuyant C; Walzer T; Vie H; Perrot I; Goutagny N; Caux C; Valladeau-Guilemond J
Int J Cancer; 2015 Mar; 136(5):1085-94. PubMed ID: 25046660
[TBL] [Abstract][Full Text] [Related]
22. Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer.
Veglia F; Tyurin VA; Mohammadyani D; Blasi M; Duperret EK; Donthireddy L; Hashimoto A; Kapralov A; Amoscato A; Angelini R; Patel S; Alicea-Torres K; Weiner D; Murphy ME; Klein-Seetharaman J; Celis E; Kagan VE; Gabrilovich DI
Nat Commun; 2017 Dec; 8(1):2122. PubMed ID: 29242535
[TBL] [Abstract][Full Text] [Related]
23. Heat shock protein 70: role in antigen presentation and immune stimulation.
Milani V; Noessner E; Ghose S; Kuppner M; Ahrens B; Scharner A; Gastpar R; Issels RD
Int J Hyperthermia; 2002; 18(6):563-75. PubMed ID: 12537755
[TBL] [Abstract][Full Text] [Related]
24. Toll-like Receptor 4 Engagement on Dendritic Cells Restrains Phago-Lysosome Fusion and Promotes Cross-Presentation of Antigens.
Alloatti A; Kotsias F; Pauwels AM; Carpier JM; Jouve M; Timmerman E; Pace L; Vargas P; Maurin M; Gehrmann U; Joannas L; Vivar OI; Lennon-Duménil AM; Savina A; Gevaert K; Beyaert R; Hoffmann E; Amigorena S
Immunity; 2015 Dec; 43(6):1087-100. PubMed ID: 26682983
[TBL] [Abstract][Full Text] [Related]
25. Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma.
Bachleitner-Hofmann T; Strohschneider M; Krieger P; Sachet M; Dubsky P; Hayden H; Schoppmann SF; Pfragner R; Gnant M; Friedl J; Stift A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4571-7. PubMed ID: 16954161
[TBL] [Abstract][Full Text] [Related]
26. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
27. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.
Fang H; Ang B; Xu X; Huang X; Wu Y; Sun Y; Wang W; Li N; Cao X; Wan T
Cell Mol Immunol; 2014 Mar; 11(2):150-9. PubMed ID: 24362470
[TBL] [Abstract][Full Text] [Related]
28. Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells.
Guillerme JB; Boisgerault N; Roulois D; Ménager J; Combredet C; Tangy F; Fonteneau JF; Gregoire M
Clin Cancer Res; 2013 Mar; 19(5):1147-58. PubMed ID: 23339127
[TBL] [Abstract][Full Text] [Related]
29. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
[TBL] [Abstract][Full Text] [Related]
30. Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.
Werthmöller N; Frey B; Wunderlich R; Fietkau R; Gaipl US
Cell Death Dis; 2015 May; 6(5):e1761. PubMed ID: 25973681
[TBL] [Abstract][Full Text] [Related]
31. A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.
Park HJ; Jang GY; Kim YS; Park JH; Lee SE; Vo MC; Lee JJ; Han HD; Jung ID; Kang TH; Park YM
J Immunother Cancer; 2019 Feb; 7(1):60. PubMed ID: 30819254
[TBL] [Abstract][Full Text] [Related]
32. Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling.
Bendz H; Ruhland SC; Pandya MJ; Hainzl O; Riegelsberger S; Braüchle C; Mayer MP; Buchner J; Issels RD; Noessner E
J Biol Chem; 2007 Oct; 282(43):31688-702. PubMed ID: 17684010
[TBL] [Abstract][Full Text] [Related]
33. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
[TBL] [Abstract][Full Text] [Related]
34. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake.
Todryk S; Melcher AA; Hardwick N; Linardakis E; Bateman A; Colombo MP; Stoppacciaro A; Vile RG
J Immunol; 1999 Aug; 163(3):1398-408. PubMed ID: 10415040
[TBL] [Abstract][Full Text] [Related]
35. β-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8⁺ T cells.
Liang X; Fu C; Cui W; Ober-Blöbaum JL; Zahner SP; Shrikant PA; Clausen BE; Flavell RA; Mellman I; Jiang A
J Leukoc Biol; 2014 Jan; 95(1):179-90. PubMed ID: 24023259
[TBL] [Abstract][Full Text] [Related]
36. Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy.
Orange DE; Jegathesan M; Blachère NE; Frank MO; Scher HI; Albert ML; Darnell RB
Prostate Cancer Prostatic Dis; 2004; 7(1):63-72. PubMed ID: 14999241
[TBL] [Abstract][Full Text] [Related]
37. Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4.
Aosai F; Rodriguez Pena MS; Mun HS; Fang H; Mitsunaga T; Norose K; Kang HK; Bae YS; Yano A
Cell Stress Chaperones; 2006; 11(1):13-22. PubMed ID: 16572725
[TBL] [Abstract][Full Text] [Related]
38. ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II.
Schnurr M; Orban M; Robson NC; Shin A; Braley H; Airey D; Cebon J; Maraskovsky E; Endres S
J Immunol; 2009 Feb; 182(3):1253-9. PubMed ID: 19155470
[TBL] [Abstract][Full Text] [Related]
39. Impaired cross-presentation of CD8α+ CD11c+ dendritic cells by Japanese encephalitis virus in a TLR2/MyD88 signal pathway-dependent manner.
Aleyas AG; Han YW; Patil AM; Kim SB; Kim K; Eo SK
Eur J Immunol; 2012 Oct; 42(10):2655-66. PubMed ID: 22706912
[TBL] [Abstract][Full Text] [Related]
40. Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components.
Lin TJ; Lin HT; Chang WT; Mitapalli S P; Hsiao PW; Yin SY; Yang NS
Mol Cancer; 2015 Sep; 14():174. PubMed ID: 26403780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
